Integra LifeSciences Holdings Corporation — Company profile
Healthcare · Medical Devices · United States
Last price 12.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 998.19M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Details
| Name | Integra LifeSciences Holdings Corporation |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 4427 |
| Founded | 1989 |
| Ipo Date | 1995-08-16 |
| Ceo | Stuart Essig |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US4579852082 |
| Cusip | 457985208 |
| Cik | 0000917520 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Stuart M. Essig Ph.D. | Chief Executive Officer, President and Chairman |
| Lea Daniels Knight | Executive Vice President and Chief Financial Officer |
| Robert T. Davis Jr. | Executive Vice President of Tissue Reconstruction and Distributed Technologies |
| Michael J. McBreen | Executive Vice President and Chief Commercial Officer |
| Harvinder Pal Singh | Executive Vice President and President of International Business |
| Jeffrey A. Mosebrook | Senior Vice President of Finance and Principal Accounting Officer |
| Teshtar Elavia | Corporate Vice President and Chief Technology Officer |
| Christopher Ward | Senior Director of Investor Relations |
| Michael D. Hutchinson | Executive Vice President, Chief Legal Officer and Secretary |
| Laurene Isip | Vice President of Global Corporate Communications and Public Relations |
Contact
| Address | 1100 Campus Road, Princeton, New Jersey 08540, United States |
| Phone | 609 275 0500 |
| Website | https://www.integralife.com |